Factors predicting cost-effectiveness of adult spinal deformity surgery at 2 years

被引:22
作者
Fischer C.R. [1 ,2 ]
Terran J. [2 ]
Lonner B. [2 ]
McHugh B. [3 ]
Warren D. [4 ]
Glassman S. [5 ]
Bridwell K. [6 ]
Schwab F. [2 ]
Lafage V. [2 ]
机构
[1] Department of Orthopaedic Surgery, Columbia University Medical Center, New York, NY, 10032, 622 West 168th Street
[2] Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, NY 10003
[3] Department of Neurosurgery, Yale University, New Haven, CT 06520-8082
[4] Department of Neurosurgery, Vancouver Island Health Authority, Victoria, BC
[5] Department of Orthopaedics, Norton Leatherman Spine Center, Louisville, KY
[6] Department of Orthopaedics, Washington University in St. Louis, St. Louis, MO 63110, 660 S. Euclid Ave
基金
美国国家卫生研究院;
关键词
Adult spinal deformity; Cost-effectiveness; QALY; Spinal fusion;
D O I
10.1016/j.jspd.2014.04.011
中图分类号
学科分类号
摘要
Objective To identify preoperative factors that lead to cost-effectiveness at 2 years' follow-up in the setting of surgical treatment for adult spinal deformity. Methods Retrospective analysis of a prospective, consecutive, multicenter database including 514 patients who underwent surgery for adult spinal deformity. The change in quality-adjusted life-years (QALY) was calculated from the 2-year change in Oswestry Disability Index (ODI). Medicare coding was used to determine the direct costs based on diagnosis-related group and Relative Value Unit reimbursement. Analysis was performed to determine which factors were associated with a cost/QALY less than $100,000, making the procedure cost-effective. Results The average QALY change for all patients in this study was 0.15 and the average cost/QALY was $243,761.97. A total of 56 patients (10.4%) had a cost/QALY of less than $100,000 at 2-year follow-up. Those patients were mostly female (89%), with a mean age of 60 years and the following diagnoses: 18 (32.1%) adult idiopathic scoliosis, 12 (35.7%) adult de novo scoliosis, 87 (14.3%) sagittal imbalance, and 10 (17.9%) other scoliosis. The Health-Related Quality of Life ODI and Scoliosis Research Society (SRS) instruments were all associated with cost-effectiveness except SRS-Mental. Factors associated with cost-effectiveness were age greater than 55 years, adult de novo scoliosis, prior surgery, higher preoperative sagittal vertical axis, lower maximum Cobb angles, 8 or fewer fusion levels, lower blood loss, worse global alignment classification, and global sagittal malalignment. Combined anterior-posterior surgeries were negatively associated with cost-effectiveness. Preoperative ODI scores between 60 and 70 and SRS Pain and Activity subscores more than 4 minimally clinically important difference points below the normative values had the highest percentage of cost-effective patients. Conclusions The QALY change is 0.15 and the cost/QALY of adult deformity surgery is $243,761.97 at 2 years. Patients with higher preoperative morbidity are more likely to be cost-effective with a cost/QALY less than $100,000. © 2014 Scoliosis Research Society.
引用
收藏
页码:415 / 422
页数:7
相关论文
共 37 条
[1]  
Carter O.D., Haynes S.G., Prevalence rates for scoliosis in US adults: Results from the first National Health and Nutrition Examination Survey, Int J Epidemiol, 16, pp. 537-544, (1987)
[2]  
Francis R.S., Scoliosis screening of 3,000 college-aged women: The Utah Study - Phase 2, Phys Ther, 68, pp. 1513-1516, (1988)
[3]  
Glassman S.D., Bridwell K., Dimar J.R., Et al., The impact of positive sagittal balance in adult spinal deformity, Spine (Phila Pa 1976), 30, pp. 2024-2029, (2005)
[4]  
Grubb S.A., Lipscomb H.J., Coonrad R.W., Degenerative adult onset scoliosis, Spine (Phila Pa 1976), 13, pp. 241-245, (1988)
[5]  
Kostuik J.P., Bentivoglio J., The incidence of low back pain in adult scoliosis, Acta Orthop Belg, 47, pp. 548-559, (1981)
[6]  
Robin G.C., Span Y., Steinberg R., Et al., Scoliosis in the elderly: A follow-up study, Spine (Phila Pa 1976), 7, pp. 355-359, (1982)
[7]  
Schwab F., Dubey A., Pagala M., Et al., Adult scoliosis: A health assessment analysis by SF-36, Spine (Phila Pa 1976), 28, pp. 602-606, (2003)
[8]  
Laupacis A., Feeny D., Detsky A.S., Tugwell P.X., How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations, CMAJ, 146, pp. 473-481, (1992)
[9]  
Rihn J.A., Berven S., Allen T., Et al., Defining value in spine care, Am J Med Qual, 24, (2009)
[10]  
Smith H.E., Rihn J.A., Brodke D.S., Et al., Spine care: Evaluation of the efficacy and cost of emerging technology, Am J Med Qual, 24, (2009)